Dengue Vaccine, Pharmaceutical Composition Comprising the Same, Nucleotide Sequence and Antibody Composition

Yee-Shin Lin (Inventor)

Research output: Patent

Abstract

The present invention relates to a dengue vaccine, a pharmaceutical composition comprising the same, a nucleotide sequence, and an antibody composition. The dengue vaccine of the present invention includes chimeric nonstructural protein 1, which comprises N-terminus of DV NS1 from amino-acid residues 1 to 270 and C-terminus of JEV NS1 from amino-acid residues 271 to 352 (designated DJ NS1).
Translated title of the contribution登革疫苗、包含該登革疫苗之醫藥組合物、核?酸序列、以及抗體組成物
Original languageEnglish
Patent number2428221
Publication statusPublished - 1800

Fingerprint Dive into the research topics of 'Dengue Vaccine, Pharmaceutical Composition Comprising the Same, Nucleotide Sequence and Antibody Composition'. Together they form a unique fingerprint.

Cite this